These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 25879020)
1. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT. Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020 [TBL] [Abstract][Full Text] [Related]
2. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients. Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581 [TBL] [Abstract][Full Text] [Related]
3. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET. Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862 [TBL] [Abstract][Full Text] [Related]
4. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT. Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730 [TBL] [Abstract][Full Text] [Related]
6. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? Kim TJ; Park CM; Goo JM; Lee KW AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma]. Liu WK; Li XD; Quan JT; Ouyang X; Zheng H Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):114-6. PubMed ID: 25613623 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
9. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT. Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407 [TBL] [Abstract][Full Text] [Related]
10. F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung. Takahashi Y; Takashima S; Watanabe S; Tomita Y; Hakucho T; Miyake C; Morimoto D; Hosoki T; Nakanishi K; Higashiyama M Acta Radiol; 2013 Mar; 54(2):164-8. PubMed ID: 23138022 [TBL] [Abstract][Full Text] [Related]
11. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose. Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Bar-Shalom R; Kagna O; Israel O; Guralnik L Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145 [TBL] [Abstract][Full Text] [Related]
13. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT. Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128 [TBL] [Abstract][Full Text] [Related]
14. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT. Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884 [TBL] [Abstract][Full Text] [Related]
15. Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis. Zhao L; Tong L; Lin J; Tang K; Zheng S; Li W; Cheng D; Yin W; Zheng X Eur Radiol; 2015 Jul; 25(7):1837-44. PubMed ID: 25636419 [TBL] [Abstract][Full Text] [Related]
16. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG. Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618 [TBL] [Abstract][Full Text] [Related]
17. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma. Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Kulkarni M; Laskar SG; Rangarajan V Nucl Med Commun; 2014 Aug; 35(8):864-9. PubMed ID: 24751701 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. Goudarzi B; Jacene HA; Wahl RL J Nucl Med; 2008 Oct; 49(10):1585-92. PubMed ID: 18794276 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors. Kawada N; Uehara H; Hosoki T; Takami M; Shiroeda H; Arisawa T; Tomita Y Pancreas; 2015 May; 44(4):655-9. PubMed ID: 25815646 [TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]